Nanoparticulate vaccine inhibits tumor growth via improved T cell recruitment into melanoma and huHER2 breast cancer

The coordinated delivery of both antigen and adjuvants in polymeric nanoparticles led to enhanced infiltration of T cells into the tumor microenvironment, which dramatically inhibited the cancer disease progression.168